D41.00 represents a clinical diagnosis where a renal mass or tumor has been identified, but its biological behavior—specifically whether it is benign or malignant—cannot be definitively determined through initial radiological or histological examination. In the ICD-10-CM classification, 'uncertain behavior' refers to a specific pathological state where a tumor exhibits morphological characteristics common to both benign and malignant growth, or where the clinical course is unpredictable. This code is often applied to complex cystic renal masses (such as Bosniak Category III or IV lesions), certain types of renal oncocytomas that may harbor malignant components, or multi-locular cystic renal neoplasms of low malignant potential. Because of the uncertainty, these cases typically require surgical evaluation, such as a partial or radical nephrectomy, or rigorous long-term surveillance with periodic computed tomography (CT) or magnetic resonance imaging (MRI) to monitor for growth or architectural changes.
Clarify the distinction between uncertain and unspecified behavior. Uncertain behavior is a clinical or histological determination where the tissue behavior cannot be predicted as benign or malignant. Do not use this code for a mass whose pathology is simply not yet available; in that case, an unspecified code from the D49 series may be more appropriate.
Example: Patient with a 3 cm renal mass in the kidney of unknown side. Pathology report from recent biopsy describes a spindle cell neoplasm with features that make it impossible to exclude malignancy, resulting in a diagnosis of neoplasm of uncertain behavior. Patient has concurrent stage 3 chronic kidney disease and hypertension, requiring careful monitoring of renal function and blood pressure during the diagnostic workup.
Billing Focus: Identify the documentation of histologic uncertainty or the specific tumor type classified by ICD-10 as uncertain behavior.
Prioritize laterality documentation to avoid the unspecified kidney code. D41.00 should only be used when the medical record truly lacks information on which kidney is affected, which is rare in the presence of modern imaging.
Example: Physician note specifies a neoplasm of uncertain behavior of the kidney. Review of the accompanying CT abdomen and pelvis with contrast indicates the mass is located in the lower pole of the left kidney. Documentation should be updated to D41.02 to reflect laterality. Patient presents with persistent gross hematuria and tobacco use disorder.
Billing Focus: Laterality (Right, Left, or Unspecified).
Document associated signs and symptoms that led to the discovery of the neoplasm. Include symptoms such as hematuria, flank pain, or palpable mass, as these support medical necessity for diagnostic procedures.
Example: Patient presents with sharp right-sided flank pain and microscopic hematuria. Imaging revealed a solid mass in the kidney. Biopsy confirmed a neoplasm of uncertain behavior. Documentation links the flank pain and hematuria as symptomatic manifestations of the renal neoplasm. Management includes urological referral for potential partial nephrectomy.
Billing Focus: Clinical indications for diagnostic testing and procedural medical necessity.
Incorporate the Bosniak classification or other imaging-based scoring systems when documenting renal cysts or masses that exhibit uncertain behavior.
Example: Renal ultrasound demonstrates a Bosniak Category III complex cystic mass in the kidney. Due to the high risk of malignancy but lack of definitive features, it is documented as a neoplasm of uncertain behavior. Patient is scheduled for a follow-up MRI to further characterize the lesion. Patient also has a history of type 2 diabetes with nephropathy.
Billing Focus: Specificity of imaging findings and diagnostic criteria used.
Ensure the medical record reflects the multi-disciplinary approach often required for uncertain neoplasms, including pathology, radiology, and urology consultations.
Example: Neoplasm of uncertain behavior of the kidney was discussed in a multi-disciplinary tumor board. Radiologic findings were compared with the percutaneous biopsy results. The consensus is for close interval surveillance every 6 months. Patient is counseled on the importance of follow-up due to the uncertain potential of the lesion.
Billing Focus: Documentation of collaborative care and specialized consultation.
Used for the initial evaluation of a kidney mass with low complexity MDM.
Routine follow-up for a stable neoplasm of uncertain behavior.
Management of a renal mass that requires complex review of imaging or pathology and treatment planning.
Detailed initial consultation for a new renal mass with multiple comorbid factors.
Directly used to determine the behavior of a renal neoplasm.
Primary imaging modality for identifying and characterizing the size and location of a kidney neoplasm.
Used for detailed characterization of renal masses when CT is inconclusive or contrast is contraindicated.
The surgical treatment of choice for a neoplasm of uncertain behavior to prevent potential malignancy spread.
The pathology service that results in the diagnosis of uncertain behavior.
Initial screening tool or follow-up imaging for renal lesions.